The present invention provides Fc-erythropoietin ("Fc-EPO") fusion proteins with improved pharmacokinetics. Nucleic acids, cells, and methods relating to the production and practice of the invention are also provided.
Web www.patentalert.com
< Use of gp130 activators in diabetic neuropathy
> Methods of screening for potential therapeutics for diseases associated with G-protein coupled receptor HM74a
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT